Ningbo Maxcon Medical Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Ningbo Maxcon Medical Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MAXCON and MEDWASTE 48 QUALITY PORTABLE MEDICAL WASTE SOLUTIONS. The owner is based in District, Ningbo.

District, Ningbo 315157 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ningbo Maxcon Medical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ningbo Maxcon Medical Technology Co., Ltd. have?

Ningbo Maxcon Medical Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Ningbo Maxcon Medical Technology Co., Ltd. file in?

Ningbo Maxcon Medical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Ningbo Maxcon Medical Technology Co., Ltd.'s most well-known trademarks?

Ningbo Maxcon Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MAXCON and MEDWASTE 48 QUALITY PORTABLE MEDICAL WASTE SOLUTIONS. These are among 2 currently registered trademarks in the portfolio.

What is Ningbo Maxcon Medical Technology Co., Ltd.'s trademark registration success rate?

Ningbo Maxcon Medical Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.